Hester Biosciences announces Q3 and 9M FY22 results
Sales up by nine per cent and 23 per cent for Q3 and 9M FY22, respectively
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Filling the gaps in India’s pharma manufacturing supply chain
The lessons of the past – of spiralling API costs, overdependence on a shrinking list of API makers – have been well learnt
India awaits a forward-looking budget where policymakers should reciprocate in full spirit
Yogesh Mudras, Managing Director, Informa Markets, India, opines that it is time for well-thought actions to maximise the revenue…
IIT Madras-led international research team identifies gene/protein variation in Indians and other…
They found that 15 per cent of Indian and other South Asian populations had this variation and that people carrying this variant…
China to strengthen anti-monopoly efforts in pharma industry
The action follows November’s regulatory guidelines to stamp out monopolies in Active Pharmaceutical Ingredients (APIs)
US FDA expands deployment of Waters Corporation Software to support its medical products testing…
Transition to electronic records management system will speed data retrieval, automate essential audit and archival functions, and…
Eris Lifesciences Q3FY22 revenues at Rs 3,322 million, up seven per cent YoY
The company's EBITDA stood at Rs 1,217 million, up 13.5 per cent YoY and PAT stood at Rs 1,008 million, up 11.8 per cent YoY
National R&D policy to bolster Indian pharma sector, say experts
The experts discussed regulatory reforms and ease of doing business during Health & Wellness Week at India Pavilion
Glenmark gets nod from US FDA for generic drug
The product is a generic version of Bausch Health US LLC's MetroGel-Vaginal
Health Minister launches NIPER research portal
The research portal has been created with the aim to disseminate the information about all the NIPERs and their research…